Type III interferons disrupt the lung epithelial barrier upon viral recognition.

Broggi A, Ghosh S, Sposito B, Spreafico R, Balzarini F, Lo Cascio A, Clementi N, De Santis M, Mancini N, Granucci F, Zanoni I. · 2020

Read Type III interferons disrupt the lung epithelial barrier upon viral recognition. by Broggi A, Ghosh S, Sposito B, Spreafico R, Balzarini F, Lo Cascio A, Clementi N, De Santis M, Mancini N, Granucci F, Zanoni I. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7292499.txt.

Description

Broggi and co-authors show that a class of antiviral signal, type III interferons, can damage the lung lining it is meant to protect. Their study appeared in Science. Interferons switch on antiviral defenses after a virus is detected. Type III interferons act mainly at mucosal surfaces and were thought to protect without the damaging inflammation of other types, making them candidates for COVID-19 treatment.

In COVID-19 patients, worse illness tracked with high levels of type I and III interferons in the lung. In mice, type III interferon released by lung dendritic cells after exposure to synthetic viral RNA injured the airway lining. That damage raised susceptibility to lethal bacterial infections on top of the virus. The findings complicate plans to use these interferons as straightforward therapy.

Catalog record

CREATORBroggi A, Ghosh S, Sposito B, Spreafico R, Balzarini F, Lo Cascio A, Clementi N, De Santis M, Mancini N, Granucci F, Zanoni I.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7292499

Browse the full library · About the Tower of Babel